Role of testosterone binding to the androgen receptor in male sexual differentiation of patients with 5α-reductase deficiency

1979 ◽  
Vol 11 (4) ◽  
pp. 1385-1390 ◽  
Author(s):  
Marc Maes ◽  
Charles Sultan ◽  
Nadia Zerhouni ◽  
Stephen W. Rothwell ◽  
Claude J. Migeon
2009 ◽  
Vol 65 ◽  
pp. S11
Author(s):  
S. Marc Breedlove ◽  
Damian G. Zuloaga ◽  
Cynthia L. Jordan

2017 ◽  
Author(s):  
Camerron M. Crowder ◽  
Christopher S. Lassiter ◽  
Daniel A. Gorelick

ABSTRACTAndrogens act through the nuclear androgen receptor (AR) to regulate gonad differentiation and development. In mice, AR is required for spermatogenesis, testis development and formation of external genitalia in males and oocyte maturation in females. However, the extent to which these phenotypes are conserved in nonmammalian vertebrates is not well understood, because mutations in AR have not been generated in any other species. Here, we generate zebrafish with a mutation in the ar gene and examine the role of AR on sexual differentiation and gonad development. We find that zebrafish AR is not required for male sexual differentiation, since a portion of ar mutants develop a testis. However, we show that in zebrafish, as in mice, AR is required for the development of secondary sexual characteristics and for proper organization of the testis in males and for oocyte maturation in females. Additionally, we find that zebrafish ar mutant males have functional, mature sperm present in their testis, but are infertile due to an inability to release sperm. These findings suggest that AR is required for male sexual development and fertility, but not essential for sexual differentiation in zebrafish. The ar mutant we developed will be useful for modeling human endocrine function in zebrafish.


2021 ◽  
Author(s):  
Neelima Dhingra

Steroidal 5α-reductase is a system of NADPH dependent enzyme that catalyzes the irreversible conversion of Δ4–3-ketosteroid precursor (testosterone) to its corresponding 5α-reduced metabolite (dihydrotestosterone). Initial role of DHT was discovered through males pseudohermaphroditism, a genetic disorder with complete or partial 5α-reductase deficiency accompanied with features at critical juncture of fetal and postnatal development. However, excessive DHT production, has brought a revolution in revealing the etiology of complications like prostate cancer and benign prostatic hyperplasia. Over the last two decades, converging lines of evidences have highlighted the role of 5α-reductase inhibitors in the treatment of these androgen dependent disorders. Finasteride and Dutasteride, are the two clinically approved inhibitors available in the market, that helps in reducing the prostate volume by blocking the 5a-reductase enzyme.


1992 ◽  
Vol 38 (5-6) ◽  
pp. 226-229 ◽  
Author(s):  
J.A. Batch ◽  
D.M. Williams ◽  
H.R. Davies ◽  
B.D. Brown ◽  
B.A.J. Evans ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document